Keywords: ADAMTS13; disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; aHUS; atypical hemolytic uremic syndrome; BU; Bethesda units; CF; complement factor; CFHR; complement factor H-related; HUS; hemolytic uremic syndrome; iTTP; auto
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ADAMTS13; TTP; Complement-mediated HUS; Pregnancy; Thrombotic microangiopathies;
Keywords: Autopsy; Extranodal marginal zone lymphoma; MALT lymphoma; Thrombotic thrombocytopenic purpura; ADAMTS13;
Keywords: Thrombotic thrombocytopenic purpura; Refractory disease; ADAMTS13; Rituximab; Immunotherapy;
Keywords: LAA; left atrial appendage; ADAMTS13; a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; ADMA; asymmetric dimethylarginine; AF; atrial fibrillation; ANP; atrial natriuretic peptide; BMI; body mass index; BSA; body surface a
Keywords: Von Willebrand factor; Glomerular basement membrane; Kidney; Neutrophils; ADAMTS13; Elastase;
Keywords: ventricular assist device; von Willebrand factor; bleeding; shear stress; multimer; ADAMTS13;
Keywords: Cerebral hemorrhage; von Willebrand factor; ADAMTS13; plasminogen activators;
Keywords: NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; ASH; alcoholic steatohepatitis; ADAMTS13; a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; CVD; cardiovascular disease; VT; venous thromboembo
Keywords: Antiplatelet therapy; Platelet-vessel wall interaction; Atherothrombosis; Vascular inflammation; ADAMTS13; a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; COX; cyclooxygenase; GP; glycoprotein; NO; nitric oxide; NET; neu
Keywords: Thrombotic thrombocytopenic purpura (TTP); congenital TTP; ADAMTS13; von Willebrand factor (vWF) protease; ultralarge vWF (ULvWF); complement; eculizumab; terminal complement pathway; atypical hemolytic uremic syndrome (aHUS); thrombotic microangiopathy (
Keywords: Thrombotic thrombocytopenic purpura; Hemolytic uremic syndrome; ADAMTS13; Complement activation; Plasma therapy; Eculizumab;
Keywords: Hemorrhagic shock; Multi-organ failure; Hemorrhagic shock markers; ADAMTS13; HSP27; sP-Selectin
Keywords: Thrombotic thrombocytopenic purpura; ADAMTS13; Rituximab; Immunotherapy
Keywords: Postpartum; TTP; TMA; ADAMTS13; HELLP
Keywords: Thrombotic thrombocytopenic purpura; Atypical hemolytic uremic syndrome; ADAMTS13; Complement activation; Diagnosis
Keywords: AP; alternative pathway; aHUS; atypical hemolytic syndrome; ADAMTS13; a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; AP; alternative pathway; CCP; complement control protein domain; DDD; dense deposit disease; DGKE; dia
Keywords: Thrombotic thrombocytopenic purpura; ADAMTS13; Plasma exchange; Rituximab; Immunotherapy; Purpura thrombotique thrombocytopénique; ADAMTS13; Ãchanges plasmatiques; Rituximab; Immunothérapie;
Keywords: Thrombotic thrombocytopenic purpura; ADAMTS13; Clopidogrel; Hemolytic uremic syndrome; Rituximab
Keywords: ADAMTS13; Asian population; Geographical distribution; p.P475S mutation; Single nucleotide polymorphism (SNP)
Complement activation associated with ADAMTS13 deficiency may contribute to the characteristic glomerular manifestations in Upshaw-Schulman syndrome
Keywords: Upshaw-Schulman syndrome (USS); Renal biopsy; ADAMTS13; C4d;
Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support
Keywords: arterial pulsatility; bleeding; blood flow; extracorporeal membrane oxygenation; mechanical circulatory support; von Willebrand factor; ADAMTS13; A disintegrin and metalloprotease with thrombospondin type I repeats-13; CF; continuous flow; ECMO; extracorp
Review Articlevon Willebrand factor and its cleaving protease ADAMTS13 balance in coronary artery vessels: Lessons learned from thrombotic thrombocytopenic purpura. A narrative review
Keywords: Acute coronary syndrome; Thrombotic thrombocytopenic purpura; ADAMTS13;
Exploration d'ADAMTS13 dans le purpura thrombotique thrombocytopénique
Keywords: ADAMTS13; auto-anticorps anti-ADAMTS13; facteur Willebrand; microangiopathie thrombotique; plasmathérapie; purpura thrombotique thrombocytopénique; syndrome d'Upshaw-Schulman; ADAMTS13; anti-ADAMTS13 autoantibodies; Willebrand factor; thrombotic micro
Association between Von Willebrand factor, disintegrin and metalloproteinase with thrombospondin type 1 motif member 13, d-Dimer and cystatin C levels with retinopathy in type 1 diabetes mellitus
Keywords: ADAMTS13; Cystatin C; d-Dimer; Diabetes mellitus, type 1; Diabetic retinopathy; Von Willebrand factor;
Prise en charge du purpura thrombotique thrombopénique dans deux centres français : à partir de 27 patients
Keywords: Purpura thrombotique thrombocytopénique; ADAMTS13; Ãchanges plasmatiques; Rituximab; Microangiopathie thrombotique; Thrombotic thrombocytopenic purpura; ADAMTS13; Plasmatic exchange; Rituximab; Thrombotic microangiopathy;
Degradation of two novel congenital TTP ADAMTS13 mutants by the cell proteasome prevents ADAMTS13 secretion
Keywords: ADAMTS13; Von Willebrand factor-cleaving protease; Thrombotic thrombocytopenic purpura; Mutation; Congenital; Proteasome;
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group
Keywords: ADAMTS13; a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13; AH50; complement alternate pathway assay; CH50; total hemolytic complement assay; CFB; complement factor B; CFHR1; complement factor H-related protein 1; CFI; com
Update on ADAMTS13 and VWF in cardiovascular and hematological disorders
Keywords: ADAMTS13; a disintegrin-like and metalloproteinase with thrombospondin motif type 1 member 13; AF; atrial fibrillation; AMI; acute myocardial infarction; AT; arterial thrombosis; CCHD; cyanotic congenital heart disease; CVD; cardiovascular disease; CUB; t
Research ReportDelayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication
Keywords: ADAMTS13; Tissue plasminogen activator; Cerebral ischemic stroke; Therapeutic time window; Hemorrhagic complication;
No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma
Keywords: VTE; venous thromboembolism; HCC; hepatocellular carcinoma; INR; International Normalised Ration; HBV; hepatitis B virus; HCV; hepatitis C virus; ELISA; enzyme-linked immunosorbent assay; VWF; von Willebrand factor; ADAMTS13; a disintegrin and metalloprot
ADAMTS13 content and VWF multimer and triplet structure in commercially available VWF/FVIII concentrates
Keywords: Wilate®; ADAMTS13; VWF triplets; von Willebrand factor; VWF/FVIII concentrate; ADAMTS13; A Disintegrin And Metalloproteinase with a ThromboSpondin type 1 motif, member 13; Act; activity; Ag; antigen; BW; body weight; FRET; fluorescence resonance energy t
Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke
Keywords: ADAMTS13; VWF antigen; Stroke; TIA; Platelets; PFA-100®
Full Length ArticleADAMTS13 gene variants and function in women with preeclampsia: A population- based nested case- control study from the HUNT Study
Keywords: ADAMTS13; a disintegrin-like and metalloprotease with thrombospondin type 1 motifs, member 13; TTP; thrombotic thrombocytopenic purpura; HUNT; Nord-Trøndelag Health Study; ADAMTS13; Mutations; Preeclampsia; Case-control; The HUNT study;
Hantavirus infection-induced thrombocytopenia triggers increased production but associates with impaired aggregation of platelets except for collagen
Keywords: HCPS; hantavirus cardiopulmonary syndrome; PUUV; Puumala virus; NE; nephropathia epidemica; AKI; acute kidney injury; ADAMTS13; a thrombospondin type 1 domain 13; PAI-1; plasminogen activator inhibitor 1; HTNV; Hantaan virus; MPV; mean platelet volume; IP
The co-influence of VWD type 2B/2M mutations in the A1 domain and platelet GPIbα on the rate of cleavage to VWF by ADAMTS13
Keywords: ADAMTS13; a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13; VWF; von Willebrand factor; VWD; von Willebrand disease; RIPA; ristocetin-induced platelet aggregation; BSA; bovine serum albumin; FRETS-VWF73; fluorescence reson
Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
Keywords: ADAMTS13; Thrombotic thrombocytopenic purpura; Autoantibodies; von Willebrand factor
Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy
Keywords: TMA; Platelet activation; ADAMTS13; sGPVI;
Inherited ADAMTS13 deficiency (Upshaw-Schulman syndrome): A short review
Keywords: ADAMTS13; Thrombotic thrombocytopenic purpura; Upshaw-Schulman syndrome; Mutation;
Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement
Keywords: ADAMTS13; A disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13; CV; Coefficient of variation; FRETS-VWF73; Fluorescence resonance energy transfer-VWF73; HELLP; Hemolysis elevated liver enzymes low platelet count; HUS; Hemolytic
Acquired TTP: ADAMTS13 meets the immune system
Keywords: ADAMTS13; TTP; Thrombotic thrombocytopenic purpura; Antibodies; Molecular mimicry; Glycosylation; Review;
De novo thrombotic microangiopathy after non-renal solid organ transplantation
Keywords: Thrombotic microangiopathy; Calcineurin inhibitor; mTOR inhibitor; Plasma exchange; ADAMTS13; von Willebrand Factor; Organ transplantation; Liver transplantation; Lung transplantation; Intestinal transplantation; Heart transplantation;
Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis
Keywords: von Willebrand factor; ADAMTS13; Myocardial infarction; Coronary heart disease; Ischemic stroke
Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation
Keywords: ADAMTS13; a disintegrin and metalloprotease with thrombospondin type I domain 13; VWF; Von Willebrand factor; VWFpp; VWF propeptide; UL-VWFM; unusually large Von Willebrand factor multimer; LDLT; living donor liver transplantation; TMA; Thrombotic microan
Inverse correlations between serum ADAMTS13 levels and systolic blood pressure, pulse pressure, and serum C-reactive protein levels observed at a general health examination in a Japanese population: A cross-sectional study
Keywords: ADAMTS13; Inflammation; A cross-sectional study;
Simvastatin Increases ADAMTS13 Expression in Podocytes
Keywords: ADAMTS13; A disintegrin-like and metalloprotease with thrombospondin type 1 repeats 13; VWF; von Willebrand factor; TTP; thrombotic thrombocytopenic purpura; HMG-CoA; 3-hydroxy-3-methylglutaryl coenzyme A; TNF-α; tumor necrosis factor-α; IL-4; interleuk
The emerging concept of residual ADAMTS13 activity in ADAMTS13-deficient thrombotic thrombocytopenic purpura
Keywords: ADAMTS13; Thrombotic thrombocytopenic purpura; Residual ADAMTS13 activity; VWF; Upshaw-Schulman syndrome;
Hypercoagulability and cardiovascular disease in diabetic nephropathy
Keywords: Diabetic nephropathy; Von Willebrand factor; ADAMTS13; Cardiovascular disease; Hypercoagulability;